These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26900895)

  • 1. Long-term outcomes of brief, intensive CBT for specific phobias: The negative impact of ADHD symptoms.
    Halldorsdottir T; Ollendick TH
    J Consult Clin Psychol; 2016 May; 84(5):465-71. PubMed ID: 26900895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting one-session treatment of children's specific phobias with attention training to positive stimuli.
    Waters AM; Farrell LJ; Zimmer-Gembeck MJ; Milliner E; Tiralongo E; Donovan CL; McConnell H; Bradley BP; Mogg K; Ollendick TH
    Behav Res Ther; 2014 Nov; 62():107-19. PubMed ID: 25156398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One session treatment for specific phobias in children: Comorbid anxiety disorders and treatment outcome.
    Ryan SM; Strege MV; Oar EL; Ollendick TH
    J Behav Ther Exp Psychiatry; 2017 Mar; 54():128-134. PubMed ID: 27474792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific phobias in youth: a randomized controlled trial comparing one-session treatment to a parent-augmented one-session treatment.
    Ollendick TH; Halldorsdottir T; Fraire MG; Austin KE; Noguchi RJ; Lewis KM; Jarrett MA; Cunningham NR; Canavera K; Allen KB; Whitmore MJ
    Behav Ther; 2015 Mar; 46(2):141-55. PubMed ID: 25645164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental Involvement in CBT for Anxiety-Disordered Youth Revisited: Family CBT Outperforms Child CBT in the Long Term for Children With Comorbid ADHD Symptoms.
    Maric M; van Steensel FJA; Bögels SM
    J Atten Disord; 2018 Mar; 22(5):506-514. PubMed ID: 25755259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
    BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis.
    Young S; Khondoker M; Emilsson B; Sigurdsson JF; Philipp-Wiegmann F; Baldursson G; Olafsdottir H; Gudjonsson G
    Psychol Med; 2015 Oct; 45(13):2793-804. PubMed ID: 26022103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-session treatment for specific phobias: a review of Öst's single-session exposure with children and adolescents.
    Ollendick TH; Davis TE
    Cogn Behav Ther; 2013; 42(4):275-83. PubMed ID: 23957749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
    van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One session treatment for pediatric blood-injection-injury phobia: A controlled multiple baseline trial.
    Oar EL; Farrell LJ; Waters AM; Conlon EG; Ollendick TH
    Behav Res Ther; 2015 Oct; 73():131-42. PubMed ID: 26313620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
    Findling RL; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; DeLeon A; Ginsberg LD
    J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):28-35. PubMed ID: 23410139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mediating role of changes in harm beliefs and coping efficacy in youth with specific phobias.
    Ollendick TH; Ryan SM; Capriola-Hall NN; Reuterskiöld L; Öst LG
    Behav Res Ther; 2017 Dec; 99():131-137. PubMed ID: 29101841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.